baber/WOPTO huggingface dataset:
Patent DE-69201216-T2 (DE)
Inventor: COLAROW LADISLAS
IPC: A23D9/06
Filed: 1992-04-15
Granted: 1995-05-18
Abstract: To protect a fatty substance which is sensitive to oxidation or a food or cosmetic product containing a fatty substance which is sensitive to oxidation, an antioxidant mixture is incorporated therein which consists of a vitamin B complex and an organic acid, especially niacinamide ascorbate, and a lecithin rich in phosphatidylcholine. The mixture makes it possible in particular to render vitamin C in fat-soluble form.
Patent DE-69207607-T2 (DE)
Inventor: DAHLBAECK BJOERN
IPC: G01N33/50
Filed: 1992-05-13
Granted: 1996-06-20
Abstract: The invention concerns an in vitro method that is particularly useful for the diagnosis of thromboembolic diseases, such as hereditary or non-heriditary thrombophilia, and to determine the risk for trombosis in connection with pregnancy, taking anti-conception pills, surgery etc. The method is characterized in that the coagulation system in a sample is activated wholly or partly in a manner known per se and incubated with activated Protein C, whereupon a substrate conversion reaction rate like clotting or conversion of a chromogenic substrate is determined. The conversion rate obtained is compared with values obtained for normal plasma samples. If the rate is enhanced, it indicates that the individual from which the sample is derived may suffer from a thromboembolic disease.
Patent DE-69208605-T2 (DE)
Inventor: ARGESE MARIA
IPC: C07C323/58
Filed: 1992-10-09
Granted: 1996-07-11
Abstract: S-carboxymethylcysteine lysine salt monohydrate <CHEM> for the preparation of a medicament having mucolytic, bronchosecretolytic and antibronchospastic activities, and a process for the preparation thereof, characterized in that L(R)-S-carboxymethylcysteine is reacted with a L(S)-lysine aqueous solution, the obtained solution is diluted with ethanol and the product is crystallized by stirring.
Patent DE-69212195-T2 (DE)
Inventor: CREEDON JOSEPH M
IPC: G01R1/073
Filed: 1992-01-02
Granted: 1996-12-19
Abstract: Apparatus for electronically testing printed circuit boards including a plurality of generally parallel test pins which have a section of reduced diameter along their length intermediate the ends thereof, and a plate having a plurality of drilled holes in which the test pins are mounted with the reduced diameter portions being located in the holes, the plate being adapted to interfere with shoulders at the ends of the sections of reduced diameter to retain the test pins in the testing apparatus. <IMAGE>
Patent DE-69219448-T2 (DE)
Inventor: CANTWELL CATHLEEN ALICE
IPC: C12N1/21
Filed: 1992-12-17
Granted: 1997-09-04
Abstract: The present invention provides isolated DNA compounds and recombinant DNA cloning and expression vectors that encode PNB esterase from Bacillus subtilis. The invention also provides host cells transformed with these vectors and a method for production of the PNB esterase by recombinant DNA techniques.
Patent DE-69230881-T2 (DE)
Inventor: POTTER ELLEN
IPC: A61K38/04
Filed: 1992-01-13
Granted: 2000-11-16
Abstract: A binding protein for Corticotropin Releasing Factor (CRF) is isolated from human plasma and partially sequenced. Using degenerate oligonucleotides based upon certain partial sequences of the isolated protein, the complete sequence for the 322-residue human precursor protein, termed CRF-BP, is deduced, which is believed to circulate in the plasma as an N-terminally shortened 298-residue mature protein. The homologous 322-residue sequence of the rat precursor protein is separately deduced. These proteins are produced recombinantly, and they are useful in the reduction of high ACTH levels in mammals caused by excess CRF and can be used to treat Cushing's Disease. They are also particularly useful in combating pituitary tumors which produce CRF and in modulating the various actions of CRF on the pituitary, the brain, the immune system and gastrointestinal blood flow. The proteins can also be used to raise blood pressure and combat hypotension in this manner. Antibodies to the proteins may be employed in diagnostic assays and in purification of the protein; they are also useful to counteract the biological effect of CRF-BPs.
Patent DE-69232620-T2 (DE)
Inventor: BRIDGES IAN GEORGE
IPC: C12N15/82
Filed: 1992-07-01
Granted: 2002-12-12
Abstract: PCT No. PCT/GB92/01187 Sec. 371 Date May 23, 1994 Sec. 102(e) Date May 23, 1994 PCT Filed Jul. 1, 1992 PCT Pub. No. WO93/01294 PCT Pub. Date Jan. 21, 1993The chemically-inducible 27 kD subunit of the enzyme glutathione-S-transferase, isoform II (GST-II-27) and sequences encoding it are provided. In particular, a genomic DNA sequence encoding the gene promoter for the GST-II-27 subunit is provided. When linked to an exogenous gene and introduced into a plant by transformation, the GST-II-27 promoter provides a means for the external regulation of expression of that exogenous gene. Transformation with DNA encoding glutathione-S-transferase polypeptides produces herbicide resistance transgenic plants.
Patent DE-69232897-T2 (DE)
Inventor: HORNE E
IPC: F24S20/20
Filed: 1992-02-24
Granted: 2003-11-06
Abstract: A solar energy system that includes a primary concentrator (12), a receiver (14) having a plurality of photovoltaic cells (26), and a prefilter (22) surrounding the receiver (14). The prefilter absorbs some of the radiation that is out of band with respect to the photovoltaic cells (26), and may include a conduit (28) for a cooling fluid. The cells on the receiver are positioned such that each cell receives the same solar energy flux (16). The receiver may include a phase change to protect the photovoltaic cells from excessive temperatures.
Patent DE-69303154-T2 (DE)
Inventor: KFIR AVI
IPC: F16B1/00
Filed: 1993-12-15
Granted: 1996-10-24
Abstract: The invention provides a paper staple (10) having at least one pair of spaced-apart depending paper-engaging prongs (12) and a bridging web (16) connected therebetween, the outer surface (18) of the bridging web having indicia (20) imprinted thereon.
Patent DE-69308392-T2 (DE)
Inventor: SEMBO SATOSHI
IPC: A01N25/34
Filed: 1993-06-23
Granted: 1997-06-12
Abstract: An artificial polyurethane-based leather support material impregnated with an insecticide, and suitable for use in animal collars, has a density of 0.3 to 0.45 g/cm<3> and comprises a polyurethane surface layer having a fine porous structure and a base layer of non-woven fabric, bonded to the polyurethane layer. The collars have an excellent effect in exterminating insect pests such as fleas and ticks that inhabit body hairs of pets, such as dogs and cats.
Patent DE-69312655-T2 (DE)
Inventor: SHIMAMUNE TAKAYUKI
IPC: C25B1/46
Filed: 1993-12-10
Granted: 1997-11-27
Abstract: The present invention is intended to prevent the formation of impurities such as chlorate in electrolysis using the ion exchange membrane method, without resorting to the addition of hydrochloric acid to counter the migration of alkali hydroxide from the cathode compartment to the anode compartment. The method of the present invention includes feeding a portion of an aqueous solution of an alkali chloride (as the raw material) into an auxiliary electrolytic cell (1) of the cation exchange membrane (2) type in which the anode (5) is a hydrogen gas electrode, thereby effecting electrolysis to generate hydrochloric acid in the anode compartment (3), and then feeding the hydrochloric acid-containing aqueous solution of alkali chloride into the main electrolytic cell (11), thereby neutralizing the alkali hydroxide which migrates from the cathode compartment (10). This method inherently forms hydrochloric acid in the system, obviating the need for having an additional facility for synthesis of hydrochloric acid, thus permitting the efficient production of alkali hydroxide and chlorine without the addition of hydrochloric acid. <IMAGE>
Patent DE-69314090-T2 (DE)
Inventor: SPAHN ROBERT G
IPC: H01J37/32
Filed: 1993-05-25
Granted: 1998-03-12
Abstract: A method is disclosed for producing Ag/Ni composite ion selective electrode on polymer substrates. By utilizing a nitrogen glow discharge pretreatment of the polymer substrate, silver may be deposited directly thereon. Further, because of the glow discharge pretreatment, aging of the silver layer prior to nickel deposition and bleaching operation is not necessary. <IMAGE>
Patent DE-69322549-T2 (DE)
Inventor: LAMPSON BUTLER
IPC: G06F11/14
Filed: 1993-06-23
Granted: 1999-06-24
Abstract: A two-phase commit protocol for a distributed transaction processing system employs the presumed-commit configuration, with the exception that the new presumed-commit protocol coordinator needs to force-write only a "commit" log record for committed transactions, not the previous force writing of two log records. To answer inquiries from subordinate processes following a crash or loss of communications, the transactions are numbered in increasing order, identified by a transaction ID (T_ID). The commit protocol is not allowed to begin unless the transaction ID of the committing transaction is within some preselected range of numbers starting from the highest-numbered stably-recorded transaction ID. That is, if the transaction number is too far removed from the highest TID of a stably stored log record disk stored and able to survive a crash), then log records are written to disk until this condition holds. Most commit transactions can, however, proceed without waiting for a disk write (forced log), and so performance is improved. A technique is disclosed for circumscribing the set of indeterminate transactions (not known whether they committed, aborted or never started) so that information is small. It must be "permanently" retained, but the coordinator can store some of it in a cache (volatile memory) to answer inquiries. <IMAGE>
Patent DE-69327059-T2 (DE)
Inventor: LEDDEN DAVID
IPC: G01N33/569
Filed: 1993-09-02
Granted: 2000-04-13
Abstract: The invention relates to a process for making a test element, such as an analytical test element. Compositions of matter, such as analyte specific receptors, are treated to carry a charge. These are then applied to test carriers treated to carry a charge opposite that of the composition of matter. Interaction of charge fixes the composition of matter to the test element.
Patent DE-69405743-T2 (DE)
Inventor: HARRIS VICTOR
IPC: F02D9/06
Filed: 1994-06-16
Granted: 1998-03-12
Abstract: PCT No. PCT/GB94/01300 Sec. 371 Date Dec. 14, 1995 Sec. 102(e) Date Dec. 14, 1995 PCT Filed Jun. 16, 1994 PCT Pub. No. WO94/29583 PCT Pub. Date Dec. 22, 1994According to the present invention there is provided an exhaust brake of the sliding valve gate type comprising a piston cylinder device for operating the slidable valve gate to open or close the exhaust brake, an aperture through the valve gate for relieving manifold pressure, and control means for controlling the passage of exhaust gases through the aperture in the valve gate, wherein the control means is variably selectable to control venting of exhaust gases according to driving conditions of a vehicle as determined by the driver of the vehicle.
Patent DE-69418498-T2 (DE)
Inventor: BOZZO FERDINANDO
IPC: G07C9/00
Filed: 1994-08-10
Granted: 1999-12-23
Abstract: PCT No. PCT/IT94/00135 Sec. 371 Date Jan. 30, 1997 Sec. 102(e) Date Jan. 30, 1997 PCT Filed Aug. 10, 1994 PCT Pub. No. WO96/05576 PCT Pub. Date Feb. 22, 1996A credit document connected to a customized document or card is formed of a watermarked paper support with at least one dotted safety coding in linear and cryptographic form on the basis of a key consisting of an individual code. The customized document or card incorporates a microchip for the memorization of the identification code and of at least one mathematical expression which encodes the fingerprint of one or more fingers of the user. The equipment for formation of the customized document or card, the credit documents and related validation includes a scanner for taking said fingerprints, compared with those of the owner of the customized document or card upon issuance of the document and during use at the point of sale. The watermarked paper support exhibits one or more copper-plate engraving print reliefs measured by a micrometric sensor integrated in the validation equipment. A customized credit card calls for memorization of the same parameters encoded in the related microchip.
Patent DE-69514115-T2 (DE)
Inventor: HUTTON GORDON
IPC: C07C229/22
Filed: 1995-10-09
Granted: 2000-04-20
Abstract: PCT No. PCT/GB95/02385 Sec. 371 Date Jun. 9, 1997 Sec. 102(e) Date Jun. 9, 1997 PCT Filed Oct. 9, 1995 PCT Pub. No. WO96/11181 PCT Pub. Date Apr. 18, 1996The subject invention concerns a compound of formula (X), which can be prepared from the starting material L-lysine, and converted to levobupivacaine by cyclization.
Patent DE-69523974-T2 (DE)
Inventor: HARTMAN GARY STEVEN
IPC: G01N33/52
Filed: 1995-04-28
Granted: 2002-07-04
Abstract: An incubator (36) and its cover (80) are provided for an analyzer, and especially a mechanism for raising and lowering the cover (80). Such a mechanism includes a connector (82,84) between the cover and incubator that allows the cover to be raised to a superimposed position, but not rotated. A pivot pin (90) is mounted directly between the connector and the cover (80) so that the cover (80) can be pivoted relative to the connector (82,84) to complete exposure of the incubator (36) for access. A latch (120) is provided on the connector for automatically latching the cover (80) in the raised position as soon as the cover is pivoted in the plane at least part way from the superimposed position. <IMAGE>
Patent DE-69526989-T2 (DE)
Inventor: BASTIOLI CATIA
IPC: C08L33/02
Filed: 1995-01-26
Granted: 2002-11-14
Abstract: Expanded articles of biodegradable plastic material are produced by agglomerating expanded particles with density from 0.1. to 0.003 g/gm<3> and size from 0.5 to 10 mm of diameter, made of a material comprising:  from 50 to 95% by weight of thermoplastic starch; from 0.5. to 45% by weight of at least one thermoplastic polymer; from 2 to 20% by weight of water;  characterized in that the foamed particles are prepared through a route which consists of compressing/depressurising non foamed particles or through a heating treatment by microwave. <IMAGE>
Patent DE-69527138-T2 (DE)
Inventor: NEAMTU NICOLAE
IPC: B21D31/02
Filed: 1995-03-16
Granted: 2003-01-02
Abstract: A process for manufacturing razor blades from a continuous strip of metal stock (51) by stamping a plurality of openings (12) in the strip for precise registry of the blade edge when employed in the razor and then running the stock through a device which partially slits the strip along lines which are precisely located with respect to the edges of the stock and the openings. The strip is then heat treated after which it is run through a device (55) which splits the stock along the previously slit lines to form a plurality of continuous strands containing interconnected blades disposed end to end.
Patent DE-69601228-T2 (DE)
Inventor: CAPY GILBERT
IPC: B65D65/12
Filed: 1996-05-31
Granted: 1999-06-24
Abstract: PCT No. PCT/FR96/00813 Sec. 371 Date Nov. 25, 1997 Sec. 102(e) Date Nov. 25, 1997 PCT Filed May 31, 1996 PCT Pub. No. WO96/38347 PCT Pub. Date Dec. 5, 1996A package made from a flexible pleated sheet with a central region reinforced by the addition of a second pleated sheet. Folding and unfolding is made easier by having a central area with semi-extended pleats with a side area having flattened pleats.
Patent DE-69602780-T2 (DE)
Inventor: DRIVON GILLES
IPC: C07C51/363
Filed: 1996-03-01
Granted: 2000-03-09
Abstract: Prodn. of 3-chloropropionic acid (I) comprises simultaneously adding HCl gas and acrylic acid to a mixt. of 70-100 wt.% (I) and 0-30 wt.% water or aq. HCl, and opt. continuing to add HCl gas.
Patent DE-69619780-T2 (DE)
Inventor: HIRATA NORIHIKO
IPC: C07D495/04
Filed: 1996-12-24
Granted: 2002-11-21
Abstract: A process for producing 1-hydroxythienoimidazole carboxylic acid represented by formula (2): <CHEM> wherein R<1> and R<2> are as defined in the specification; wherein said process comprises the steps of:   (a) reacting thienoimidazole represented by formula (1) with 1,4-dihalogenodimagnesium butane, in the presence of tetrahydrofuran or a mixed solvent comprising tetrahydrofuran and an aromatic solvent to produce a reaction mixture: <CHEM>  wherein R<1> and R<2> are as defined above; (b) adding the reaction mixture obtained in said step (a) and, optionally, carbon dioxide, to: (i) a solution comprising carbon dioxide and tetrahydrofuran, or (ii) a solution comprising carbon dioxide, tetrahydrofuran and an aromatic solvent to give a reaction liquid; and   (c) hydrolyzing said reaction liquid. Alternatively, a process for producing 1-hydroxythienoimidazole carboxylic acid represented by formula (2), wherein the process comprises the steps of:   (a) reacting a thienoimidazole represented by formula (1) with 1,4-dihalogenodimagnesium butane, in the presence of tetrahydrofuran or a mixed solvent comprising tetrahydrofuran and an aromatic solvent to produce a reaction mixture, and wherein the thienoimidazole represented by formula (1) is added to the 1,4-dihalogenodimagnesium butane either solely or in cake state or slurry state, wherein the cake state and slurry state are made by adding a small amount of either tetrahydrofuran or a mixed solvent comprising tetrahydrofuran and an aromatic solvent; (b) reacting the reaction mixture obtained in step (a) with carbon dioxide to produce a reaction liquid; and   (c) hydrolyzing the reaction liquid.   Additionally, a process of producing thienoimidazole carboxylic acid represented by formula (3): <CHEM> wherein R<1> and R<2> are as defined above utilizing the above processes.
Patent DE-69621201-T2 (DE)
Inventor: LAMBRACHE EMIL
IPC: G11C16/16
Filed: 1996-02-22
Granted: 2002-12-19
Abstract: A sector programmable EEPROM memory capable of emulating the byte programmable functionality of full-featured byte programmable EEPROMs. The EEPROM memory incorporates an on-chip write cache (83) used as a buffer between byte level data entered by the user system and word level data written to the main memory core. The EEPROM main memory core is divided into memory pages (32) with each memory page further divided into sub-page sectors (59-62), and each sub-page sector holding a multitude of multi-byte data words. The sub-page sectors within a memory page can be individually or collectively subjected to a program and erase cycle. The EEPROM memory incorporates an ECC unit (73) used to recover and refresh lost data in the memory core. The EEPROM memory is also capable of interruptible load cycles. <IMAGE>
Patent DE-69623280-T2 (DE)
Inventor: DUNMORE SIMON JON
IPC: A61K38/04
Filed: 1996-05-11
Granted: 2003-05-22
Abstract: A method of determining the ability of a compound to both bind to somatostatin type-5 receptor ("SSTR-5") and inhibit amylin release. The method includes obtaining a preparation, either a cell preparation or a membrane preparation, which contains SSTR-5; incubating the preparation, the compound, and a SSTR-5 ligand, at least one of the ligand and the compound being detectably labeled; determining the ability of the compound to compete against the ligand for binding to SSTR-5; if and only if the compound is determined to be able to bind to SSTR-5, obtaining pancreatic cells; incubating the compound, the pancreatic cells, and an amylin release stimulator under conditions in which the amylin release stimulator would induce release of amylin from the pancreatic cells; and determining the ability of the compound to inhibit amylin release. Also disclosed is a method of treating hyperamylinemia with a ligand selective for SSTR-5.
Patent DE-69706765-T2 (DE)
Inventor: TANAKA JIRO
IPC: B22F5/10
Filed: 1997-06-03
Granted: 2002-05-29
Abstract: A bevel gear in which the sizing can be easily effected without degrading the quality of the gear. In a sintered or forged gear having a toothed portion (1) formed on an axial end face thereof, a notched groove (4) is formed in and across an outer circumferential surface of the gear in an axial direction. The construction of the notched groove (4) is specified so that its quality is kept. <IMAGE>
Patent DE-69707611-T2 (DE)
Inventor: BRYANT HENRY UHLMAN
IPC: C07F9/59
Filed: 1997-08-27
Granted: 2002-06-20
Abstract: The instant invention provides dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods for use in the treatment of bone loss or bone resorption . The dihydronaphthalene compounds have the formula: <CHEM>  wherein   R<1> is -H, -OH, -O(C1-C4 alkyl), -OCO(C1-C6 alkyl), -O-CO-O(C1-C6 alkyl) , -O-CO-Ar, -OSO2(C2-C6 alkyl), -O-CO-OAr, where Ar is optionally substituted phenyl; R<2> is -H, -Cl, -F, C1-C4 alkyl, -OH, -O(C1-C4 alkyl), -OCO(C1-C6 alkyl), -O-CO-O(C1-C6 alkyl), -O-CO-Ar,-OSO2(C2-C6 alkyl), or -O-CO-OAr, where Ar is optionally substituted phenyl; R<3> and R<4> are, independently, R<2>, with the proviso that both R<3> and R<4> are not both. hydrogen. R<5> is 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-l-pyrrolidino, 4-morpholino, dimethylamino, diethylamino, diisopropylamino, or 1-hexamethyleneimino; and   n is 2 or 3; or a pharmaceutically acceptable salt or solvate thereof.
Patent DE-69709851-T2 (DE)
Inventor: HOERLIN ERNST
IPC: A61M15/00
Filed: 1997-01-27
Granted: 2003-02-20
Abstract: The invention relates to capsule opening arrangement for a powder inhaler device. The arrangement has a first part (4) and second part (5) which are relatively movable with respect to one another. The first part has a capsule supporting means (9) comprising an aperture (10) for supporting at least one severable capsule (11). The second part (5) contains a capsule severing means (14) fixedly located therein so as to pass across the supporting aperture (10) during relative movement of said parts (4, 5). The opening arrangement provides particular advantages in that the capsule (11), after severing, has a large open area from which powder can be extracted without any part of the capsule interfering with the powder flow.
Patent DE-69709886-T2 (DE)
Inventor: BOMBARDELLI EZIO
IPC: A61K36/00
Filed: 1997-10-08
Granted: 2002-08-22
Abstract: The present invention relates to novel pharmaceutical and cosmetic formulations with antimicrobial activity containing a) a hydrophilic extract of Krameria sp., or a pure compound from said extract, and b) a lipophilic extract of Mesua ferrea.
Patent DE-69710741-T2 (DE)
Inventor: RANE F
IPC: A61K31/4427
Filed: 1997-09-11
Granted: 2002-10-24
Abstract: Compounds of formula (1.0), their use as farnesyl transferase protein inhibitors and pharmaceutical compositions containing them are disclosed, especially compounds of formula (1.5A) wherein R<1>, R<2> and R<3> are halo, A and B are each H2, and R is as defined in the specification.
Patent DE-69715217-T2 (DE)
Inventor: COOK E
IPC: A61P19/08
Filed: 1997-03-18
Granted: 2003-08-07
Abstract: A method of treating an animal to maintain or enhance the mineral content of the bones of the animal consists of administering to the animal a safe and effective amount of CLA. Compositions for use in the method are also disclosed.
Patent DE-69720219-T2 (DE)
Inventor: DENYER STANLEY
IPC: B05B7/00
Filed: 1997-06-20
Granted: 2004-02-05
Abstract: A product dispensing system comprises a calibrated nebulizer having a nebulizer jet, mouthpiece, means for sourcing compressed air, a manifold for distributing the source of compressed air in at least one direction, a nebulizer accommodation means which is accessed by port, and a valve means for controlling the manifold and thereby the flow of compressed air to the port. The manifold and the port are linked by a length of tube, wherein the internal volume of the tube from the manifold outlet to the nebulizer jet is less than 0.7ml. <IMAGE>